Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

Offering proven success and lasting results, ketamine represents hope and healing in the treatment of depression, anxiety, ...

Ketamine is an anesthetic that has hallucinogenic properties. When taken, it instantly stimulates glutamate in the brain - an ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

Ketamine is an anesthetic that has been growing in use as an off-label prescription to treat depression. Individuals can access the drug through telehealth appointments and clinics in person.

Among the vetoes rolled out with just hours to go before the next fiscal year begins at midnight: $300,000 for a study of the ...

Among young people aged 16 to 24 the misuse of ketamine has grown by 231 per cent. Read more at straitstimes.com. Read more at straitstimes.com.

Ketamine has been used for decades as an anaesthetic drug, but in the past few years, more and more psychiatrists have been using it for hard-to-treat depression ...